SFX by Ex Libris Inc.

Title:	Plugging gp120s Cavity
Source:	Structure [0969-2126] Repik, Alexander yr:2008

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Sanders, R W. "The carbohydrate at asparagine 386 on HIV-1 gp120 is not essential for." Retrovirology 5 (2008): 10-.
description	2.	Soeta, T. "Small-Molecule CD4 Mimics Interact with a Highly Conserved Pocket on HIV-1 gp120." Structure 16.11 (2008): 1689-1701.
description	3.	Abdel-Hay, M. "Kinetic spectrophotometric analysis and spectrofluorimetric analysis of ciprofloxacin hydrochloride and norfloxacin in pharmaceutical preparations using 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl)." Journal of the Chinese Chemical Society 55.4 (2008): 818-827.
description	4.	Hsu, Shang-Te D. "Entropy calculation of HIV-1 env gp120, its receptor CD4, and their complex: An analysis of configurational entropy changes upon complexation." Biophysical journal 88.1 (2005): 15-24.
description	5.	Coutsinos, Z. "[Designing an effective AIDS vaccine: Strategies and current status.]." La Revue de médecine interne 29.8 (2008): 632-41.
description	6.	Princen, K. "HIV chemokine receptor inhibitors as novel anti-HIV drugs." Cytokine & growth factor reviews 16.6 (2006): 659-77.
description	7.	Yamamoto, H. "Anti-HIV adaptive immunity: determinants for viral persistence." Reviews in medical virology 18.5 (2008): 293-303.
description	8.	De Clercq, E.. "Anti-HIV chemotherapy: Current state of the art." Medicinal chemistry research 13.6-7 (2004): 439-478.
description	9.	Park,, Alice, A. "AIDS Vaccine." Time 174.14 (2009): 12-12.
description	10.	Mahmoud, A. "The march of HIV vaccines." Science 316.5828 (2007): 1123-4.
description	11.	De Clercq, E. "Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV." International journal of antimicrobial agents 33.4 (2009): 307-320.
description	12.	Yang, ZJ J. "Capillary electrophoresis-chemiluminescence determination of norfloxacin and prulifloxacin." Analytica Chimica Acta 623.2 (2008): 231-237.
description	13.	Jacob, P. "Simultaneous determination of mecamylamine, nicotine, and cotinine in plasma by gas chromatography-mass spectrometry." Journal of pharmaceutical and biomedical analysis 23.4 (2000): 653-600.
description	14.	Chantry, D. "HIV entry and fusion inhibitors." Expert Opinion on Emerging Drugs 9.1 (2004): 1-7.
description	15.	Shaheen, F. "Co-receptor antagonists as HIV-1 entry inhibitors." Current opinion in infectious diseases 17.1 (2004): 7-16.
description	16.	Spearman, P. "HIV vaccine development: lessons from the past and promise for the future." Current HIV research 1.1 (2002): 101-20.
description	17.	von, Viktor V. "Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types." Archives of internal medicine 167.16 (2007): 1782-1790.
description	18.	Lu, R. "Design and Synthesis of Human Immunodeficiency Virus Entry Inhibitors: Sulfonamide as an Isostere for the Î±-Ketoamide Group." Journal of medicinal chemistry 50.26 (2007): 6535-6544.
description	19.	Marsh, M. "Virus entry: Open sesame." Cell 124.4 (2006): 729-740.
description	20.	Varadarajan, R. "Protein minimization of the gp120 binding region of human CD4." Biochemistry 44.49 (2006): 16192-202.